12:00 AM
 | 
May 04, 2009
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Curis preclinical data

CU-903 demonstrated strong anti-proliferative effects in breast, colon, melanoma and non-small cell lung cancer (NSCLC) cell...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >